Joana Bicker

1.7k total citations
53 papers, 1.3k citations indexed

About

Joana Bicker is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Joana Bicker has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 14 papers in Pediatrics, Perinatology and Child Health and 14 papers in Oncology. Recurrent topics in Joana Bicker's work include Epilepsy research and treatment (17 papers), Pharmacological Effects and Toxicity Studies (14 papers) and Drug Transport and Resistance Mechanisms (12 papers). Joana Bicker is often cited by papers focused on Epilepsy research and treatment (17 papers), Pharmacological Effects and Toxicity Studies (14 papers) and Drug Transport and Resistance Mechanisms (12 papers). Joana Bicker collaborates with scholars based in Portugal, Spain and United Kingdom. Joana Bicker's co-authors include Ana Fortuna, Amílcar Falcão, Gilberto Alves, Carla Vitorino, Patrício Soares‐da‐Silva, Kevin Leandro, Maria Teresa Cruz, Miren Ettcheto, Antoni Camins and Joana Gonçalves and has published in prestigious journals such as International Journal of Molecular Sciences, Antimicrobial Agents and Chemotherapy and British Journal of Pharmacology.

In The Last Decade

Joana Bicker

51 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joana Bicker Portugal 19 361 220 164 147 145 53 1.3k
Leila Moezi Iran 21 317 0.9× 135 0.6× 125 0.8× 136 0.9× 349 2.4× 81 1.5k
Sawsan A. Zaitone Egypt 30 782 2.2× 102 0.5× 203 1.2× 70 0.5× 200 1.4× 119 2.4k
Tomaž Vovk Slovenia 19 229 0.6× 57 0.3× 81 0.5× 282 1.9× 183 1.3× 53 1.3k
Dewei Shang China 17 416 1.2× 54 0.2× 91 0.6× 230 1.6× 55 0.4× 83 1.2k
Ethel A. Wilhelm Brazil 29 477 1.3× 102 0.5× 143 0.9× 68 0.5× 209 1.4× 138 2.3k
Elżbieta Wyska Poland 26 671 1.9× 107 0.5× 124 0.8× 242 1.6× 413 2.8× 111 2.0k
Awanish Mishra India 22 405 1.1× 67 0.3× 43 0.3× 162 1.1× 304 2.1× 59 1.4k
Yang Lu China 23 462 1.3× 86 0.4× 211 1.3× 30 0.2× 74 0.5× 105 1.5k
Gaetano Liso Italy 25 577 1.6× 390 1.8× 120 0.7× 67 0.5× 314 2.2× 77 2.1k

Countries citing papers authored by Joana Bicker

Since Specialization
Citations

This map shows the geographic impact of Joana Bicker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joana Bicker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joana Bicker more than expected).

Fields of papers citing papers by Joana Bicker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joana Bicker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joana Bicker. The network helps show where Joana Bicker may publish in the future.

Co-authorship network of co-authors of Joana Bicker

This figure shows the co-authorship network connecting the top 25 collaborators of Joana Bicker. A scholar is included among the top collaborators of Joana Bicker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joana Bicker. Joana Bicker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Falcão, Amílcar, et al.. (2025). Pharmacokinetics of Non-Psychotropic Phytocannabinoids. Pharmaceutics. 17(2). 236–236. 5 indexed citations
2.
Bicker, Joana, Ana Silva, Armanda E. Santos, et al.. (2025). Protective effects of irbesartan against neurodegeneration in APP/PS1 mice: Unraveling its triple anti-apoptotic, anti-inflammatory and anti-oxidant action. Biomedicine & Pharmacotherapy. 188. 118167–118167. 1 indexed citations
3.
Bicker, Joana, et al.. (2025). Chronopharmacokinetics of the antidepressant paroxetine: An in vitro and in vivo approach. Neuropharmacology. 273. 110441–110441.
5.
Bicker, Joana, Ana Fortuna, Artur Figueirinha, et al.. (2024). Effect of bioactive extracts from Eucalyptus globulus leaves in experimental models of Alzheimer’s disease. Biomedicine & Pharmacotherapy. 181. 117652–117652. 1 indexed citations
6.
Bicker, Joana, Daniela P. Lage, Camila S. Freitas, et al.. (2024). Synthesis of a dehydrodieugenol B derivative as a lead compound for visceral leishmaniasis—mechanism of action and in vivo pharmacokinetic studies. Antimicrobial Agents and Chemotherapy. 68(11). e0083124–e0083124.
7.
Gomes, Catarina, et al.. (2024). Aging and cognitive resilience: Molecular mechanisms as new potential therapeutic targets. Drug Discovery Today. 29(9). 104093–104093. 5 indexed citations
8.
Olloquequi, Jordi, Miren Ettcheto, Amanda Cano, et al.. (2023). Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment. International Journal of Molecular Sciences. 24(18). 14177–14177. 12 indexed citations
9.
Bicker, Joana, et al.. (2023). Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients. Antibiotics. 12(2). 373–373. 5 indexed citations
10.
Bicker, Joana, et al.. (2023). Air-liquid interface (ALI) impact on different respiratory cell cultures. European Journal of Pharmaceutics and Biopharmaceutics. 184. 62–82. 71 indexed citations
11.
Bicker, Joana, Anabela Almeida, Francisco Sales, et al.. (2022). Clinical Application of Pharmacokinetics to Appraise Adherence to Levetiracetam in Portuguese Epileptic Patients. Biomedicines. 10(9). 2127–2127. 1 indexed citations
12.
Almeida, Anabela, Joana Bicker, Joana Gonçalves, et al.. (2020). Pharmacokinetic Monitoring of Levetiracetam in Portuguese Refractory Epileptic Patients: Effect of Gender, Weight and Concomitant Therapy. Pharmaceutics. 12(10). 943–943. 3 indexed citations
13.
14.
Vitorino, Carla, et al.. (2020). QbD-driven development of intranasal lipid nanoparticles for depression treatment. European Journal of Pharmaceutics and Biopharmaceutics. 153. 106–120. 49 indexed citations
15.
Alves, Gilberto, et al.. (2020). Pre-Clinical Assessment of the Nose-to-Brain Delivery of Zonisamide After Intranasal Administration. Pharmaceutical Research. 37(4). 74–74. 17 indexed citations
16.
Bicker, Joana, et al.. (2020). Cystic fibrosis: Physiopathology and the latest pharmacological treatments. Pharmacological Research. 162. 105267–105267. 18 indexed citations
17.
Bicker, Joana, et al.. (2019). Liquid chromatographic methods for the determination of direct oral anticoagulant drugs in biological samples: A critical review. Analytica Chimica Acta. 1076. 18–31. 30 indexed citations
18.
Vitorino, Carla, et al.. (2019). Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges. Drug Discovery Today. 24(9). 1911–1923. 31 indexed citations
19.
Bicker, Joana, Ana Fortuna, Gilberto Alves, Patrício Soares‐da‐Silva, & Amílcar Falcão. (2017). Elucidation of the Impact of P-glycoprotein and Breast Cancer Resistance Protein on the Brain Distribution of Catechol-O-Methyltransferase Inhibitors. Drug Metabolism and Disposition. 45(12). 1282–1291. 22 indexed citations
20.
Bicker, Joana, Gilberto Alves, Ana Fortuna, Patrício Soares‐da‐Silva, & Amílcar Falcão. (2016). A new PAMPA model using an in-house brain lipid extract for screening the blood–brain barrier permeability of drug candidates. International Journal of Pharmaceutics. 501(1-2). 102–111. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026